Inventor · disambiguated record
Brian Robert Champion
Also filed as: CHAMPION BRIAN · CHAMPION BRIAN R · CHAMPION BRIAN ROBERT · CHAMPION JR BRIAN ROBERT
23 granted patents·34 pending applications·58 citations·filing 2003–2025
94Inventor score
Files withPSIOXUS THERAPEUTICS LTD13AKAMIS BIO LTD11CHAMPION BRIAN R7CHAMPION BRIAN ROBERT4BODMER MARK W3
Top patents by PatentIndex Score
57 records- 0191US10034905B2Group B adenovirus modified in the E4orf4 regionPSIOXUS THERAPEUTICS LTD·Filed 2015·Granted Jul 31, 2018·9 cites·26 claims
- 0290US10849945B2Oncolytic adenovirus encoding a B7 protein or active fragmentPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Dec 1, 2020·3 cites·23 claims
- 0388US11155622B2Virus encoding an anti-TCR-complex antibody or fragmentPSIOXUS THERAPEUTICS LTD·Filed 2016·Granted Oct 26, 2021·3 cites·20 claims
- 0487US10548929B2Oncolytic adenovirus encoding a therapeutic protein or active fragmentPSIOXUS THERAPEUTICS LTD·Filed 2017·Granted Feb 4, 2020·4 cites·13 claims
- 0585US8298547B2IgE CH3 peptide vaccineBROWN ALAN DANIEL·Filed 2009·Granted Oct 30, 2012·8 cites·16 claims
- 0684US9987314B2Oncolytic adenoviruses armed with heterologous genesPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Jun 5, 2018·6 cites·23 claims
- 0783US11000559B2Oncolytic adenovirus encoding a B7 proteinPSIOXUS THERAPEUTICS LTD·Filed 2016·Granted May 11, 2021·2 cites·21 claims
- 0883US9216229B2IgE CH3 peptide vaccineBROWN ALAN DANIEL·Filed 2013·Granted Dec 22, 2015·7 cites·14 claims
- 0983US8722053B2IgE CH3 peptide vaccineCHAMPION BRIAN ROBERT·Filed 2011·Granted May 13, 2014·5 cites·9 claims
- 1081US11439678B2Oncolytic adenoviruses armed with heterologous genesPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Sep 13, 2022·1 cites·27 claims
- 1181US8889144B2PCSK9 vaccineCHAMPION BRIAN ROBERT·Filed 2010·Granted Nov 18, 2014·7 cites·18 claims
- 1280US2024325472A1Oncolytic adenoviruses armed with heterologous genesAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 1380US2024247061A1Group b adenovirus encoding an anti-tcr-complex antibody or fragmentAKAMIS BIO LTD·Filed 2023·Application pending·0 cites
- 1476US10124028B2Oncolytic adenovirus encoding a B7 protein or active fragmentPSIOXUS THERAPEUTICS LTD·Filed 2016·Granted Nov 13, 2018·1 cites·18 claims
- 1575US2025026851A1Adenovirus armed with bispecific t cell activatorAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 1674US8475801B2IgE CH3 peptide vaccineBROWN ALAN DANIEL·Filed 2012·Granted Jul 2, 2013·2 cites·17 claims
- 1773US2024175052A1Adenovirus armed with bispecific T cell activatorAKAMIS BIO LTD·Filed 2023·Application pending·0 cites
- 1873US2021338753A1Oncolytic adenovirus encoding a b7 proteinPSIOXUS THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1971US11938159B2Oncolytic adenoviruses armed with heterologous genesAKAMIS BIO LTD·Filed 2020·Granted Mar 26, 2024·0 cites·10 claims
- 2065US10322152B2Oncolytic adenovirus encoding a B7 proteinPSIOXUS THERAPEUTICS LTD·Filed 2017·Granted Jun 18, 2019·0 cites·9 claims
- 2161US11840702B2Adenovirus armed with bispecific T cell activatorAKAMIS BIO LTD·Filed 2018·Granted Dec 12, 2023·0 cites·9 claims
- 2259US11970536B2Group B adenovirus encoding an anti-TCR-complex antibody or fragmentAKAMIS BIO LTD·Filed 2016·Granted Apr 30, 2024·0 cites·19 claims
- 2359US9481875B2PCSK9 vaccineCHAMPION BRIAN ROBERT·Filed 2014·Granted Nov 1, 2016·0 cites·30 claims
- 2459US9249233B2IgE CH3 peptide vaccinePFIZER VACCINES LLC·Filed 2014·Granted Feb 2, 2016·0 cites·17 claims
- 2558US2024180983A1Adenovirus encoding il-15AKAMIS BIO LTD·Filed 2022·Application pending·0 cites
- 2657US12258417B2Adenovirus armed with bispecific T cell engagerAKAMIS BIO LTD·Filed 2017·Granted Mar 25, 2025·0 cites·23 claims
- 2757US12049513B2Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engagerAKAMIS BIO LTD·Filed 2017·Granted Jul 30, 2024·0 cites·26 claims
- 2854US11142580B2Oncolytic virus and methodPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Oct 12, 2021·0 cites·18 claims
- 2954US2005201975A1Medical treatmentFiled 2004·Application pending·0 cites
- 3052US9987341B2PCSK9 vaccinePFIZER VACCINES LLC·Filed 2016·Granted Jun 5, 2018·0 cites·17 claims
- 3150US2018318407A1Pcsk9 vaccinePFIZER VACCINES LLC·Filed 2018·Application pending·0 cites
- 3247US2016090574A1A process for the production of adenovirusPSIOXUS THERAPUETICS LTD·Filed 2014·Application pending·0 cites
- 3345US2005220886A1Modulators of the Notch signalling pathway and uses thereof in medical treatmentBODMER MARK W·Filed 2004·Application pending·0 cites
- 3444US2005026831A1Medical treatmentFiled 2004·Application pending·0 cites
- 3544US2004203099A1Conjugate of a transport protein and a protein for modulation of notch signallingFiled 2003·Application pending·0 cites
- 3644US2006140943A1Immunotherapy using modulators of notch signallingCHAMPION BRIAN R·Filed 2005·Application pending·0 cites
- 3744US2005137130A1Medical treatmentFiled 2004·Application pending·0 cites
- 3843US2005025751A1Modulators of Notch signalling for use in immunotherapyFiled 2004·Application pending·0 cites
- 3943US2006172011A1Medical treatmentCHAMPION BRIAN R·Filed 2005·Application pending·0 cites
- 4041US2004253245A1ModulatorsFiled 2004·Application pending·0 cites
- 4140US2006204508A1Treatment of autoimmune diseases using an activator for the notch signalling pathwayCHAMPION BRIAN R·Filed 2005·Application pending·0 cites
- 4240US2006205823A1Treatment of allergic diseases using a modulator of the Notch signaling pathwayBODMER MARK W·Filed 2005·Application pending·0 cites
- 4340US2004126359A1HedgehogFiled 2003·Application pending·0 cites
- 4440US2005059093A1Method for detecting modulators of Notch signallingFiled 2004·Application pending·0 cites
- 4540US2004005631A1AssayFiled 2003·Application pending·0 cites
- 4640US2025269012A1Virus encoding transgenes to complement cellular therapyAKAMIS BIO LTD·Filed 2025·Application pending·0 cites
- 4738US2004213797A1Conjugates for the modulation of immune responsesFiled 2004·Application pending·0 cites
- 4837US2017073647A1Process for the preparation of group b adenovirusesPSIOXUS THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 4937US2017313990A1A process for the production of adenovirusPSIOXUS THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 5036US2006084588A1Modulation of immune functionBRIEND EMMANUEL C P·Filed 2005·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →